The current study also used PDX and PDO preclinical models to further verify that BAG5 knockout indeed significantly suppressed the proliferation and invasion of NSCLC, emphasizing it as a potential molecular target for NSCLC intervention. Here, BAG5 is linked to non-small cell lung carcinoma.